Preview Mode Links will not work in preview mode

Psychopharmacology and Psychiatry Updates


May 2, 2022

Do people with schizophrenia already have a high risk of metabolic effects early in the course of illness?

This episode discusses health concerns for first-episode patients, including life expectancy, metabolic conditions in drug-naïve patients, the signs of developing insulin resistance, and the approaches for early metabolic changes. 

Faculty: Stephen Marder, M.D. 
Hosts: Jessica Diaz, M.D., Flavio Guzman, M.D.